Polyclonal Rabbit anti‑Human DCLK2 / DCAMKL2 Antibody (1‑80 aa, N‑terminal, IF, WB) LS‑C383087
Polyclonal Rabbit anti‑Human DCLK2 / DCAMKL2 Antibody (1‑80 aa, N‑terminal, IF, WB) LS‑C383087
Antibody:
DCLK2 / DCAMKL2 Rabbit anti-Human Polyclonal (1-80 aa, N-terminal) Antibody
Application:
IF, WB, ELISA
Format:
Unconjugated, Unmodified
Overview
Antibody:
DCLK2 / DCAMKL2 Rabbit anti-Human Polyclonal (1-80 aa, N-terminal) Antibody
Application:
IF, WB, ELISA
Format:
Unconjugated, Unmodified
Specifications
Description
DCAMKL2 antibody LS-C383087 is an unconjugated rabbit polyclonal antibody to DCAMKL2 (DCLK2) (1-80 aa, N-terminal) from human. It is reactive with human and mouse. Validated for ELISA, IF and WB.
Target
Human DCLK2 / DCAMKL2
Synonyms
DCLK2 | CLICK-II | DCDC3 | DCDC3B | CL2 | CLIK2 | DCAMKL2 | Doublecortin-like kinase 2 | CLICK2 | DCK2
Reactivity
Human, Mouse
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated
Purification
Immunoaffinity purified
Immunogen
Synthesized peptide derived from human DCAMKL2
Epitope
1-80 aa, N-terminal
Specificity
DCAMKL2 Polyclonal Antibody detects endogenous levels of DCAMKL2 protein.
Applications
- Immunofluorescence (1:200 - 1:1000)
- Western blot (1:500 - 1:2000)
- ELISA (1:10000)
Presentation
PBS, 0.02% Sodium Azide, 50% Glycerol, 0.5% BSA
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Monkey, Bovine, Guinea pig, Hamster, Pig
Applications:
IHC, Western blot
Reactivity:
Human
Range:
0.156-10 ng/ml
Reactivity:
Human
Range:
40-10000 pg/ml
Reactivity:
Human
Range:
0.156-10 ng/ml
Species:
Human, Mouse
Applications:
IHC, Immunofluorescence, Western blot
Reactivity:
Mouse
Range:
0.312-20 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/25/2024